Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pharmacogenomics of Heparin-Induced Thrombocytopenia
Sponsor: University of Arizona
Summary
The purpose of this research is to identify genomic markers that can predict heparin-induced thrombocytopenia (HIT), which is a very serious side effect to heparin. Heparin is commonly used to prevent blood clots and the investigators may be able to identify genomic markers which can be used to prevent heparin use in people who will get HIT.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
125
Start Date
2016-03
Completion Date
2026-07
Last Updated
2024-06-27
Healthy Volunteers
No
Conditions
Interventions
Blood Draw
A one time blood draw of 150 milliliters will be performed using a vein in the participants arm. Existing venous access will be used for the blood draw in preference of new venipuncture.
Locations (1)
Banner University Medical Center - Tucson
Tucson, Arizona, United States